FDA user fees
Executive Summary
The Natl. Assn. of Pharmaceutical Mfrs. requested in an Aug. 20 letter to FDA that the agency provide a 60 day comment period on its proposal for user fees, published in the Aug. Federa/Register ("The Pink Sheet" Aug. 12, p. 8). NAPM also said FDA should hold a regulatory hearing on the issue.